<?xml version="1.0" encoding="UTF-8"?>
<p>IFN-beta is the most relevant IFN-I that should be given as early as possible to optimize antiviral therapy and avoid complications from the virus [
 <xref rid="R46" ref-type="bibr">46</xref>]. No specific dose has been validated, especially for COVID-19. The general dosing guideline is being followed.
</p>
